Tempest Therapeutics, Inc. Increase (Decrease) in Restricted Cash
Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Restricted Cash of $350.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-15
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was -$23.00K.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $373.00K.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2017 was $350.00K.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2016 was -$197.00K, a 128.93% decline from fiscal 2015.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2015 was $681.00K, a 524.77% increase from fiscal 2014.
- Tempest Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2014 was $109.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 15 month | Increase (Decrease) in Restricted Cash 18 month | Increase (Decrease) in Restricted Cash 21 month | Increase (Decrease) in Restricted Cash 24 month | Increase (Decrease) in Restricted Cash 27 month | Increase (Decrease) in Restricted Cash 30 month | Increase (Decrease) in Restricted Cash 33 month | Increase (Decrease) in Restricted Cash 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$23.00K derived: sum of 2 quarters · filed 2018-03-15 | $350.00K derived: sum of 3 quarters · filed 2018-03-15 | $350.00K 10-K · filed 2018-03-15 | ||||||||
| 2017-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $350.00K derived: sum of 2 quarters · filed 2017-11-02 | $350.00K 10-Q · filed 2017-11-02 | $350.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2017-06-30 | $373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $373.00K 10-Q · filed 2017-08-03 | $373.00K derived: sum of 3 quarters · filed 2018-03-15 | $373.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | -$109.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | -$109.00K derived: sum of 3 quarters · filed 2018-03-15 | -$197.00K 10-K · filed 2018-03-15 | ||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$109.00K derived: sum of 2 quarters · filed 2017-11-02 | -$197.00K 10-Q · filed 2017-11-02 | $45.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-06-30 | -$109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$197.00K 10-Q · filed 2017-08-03 | $45.00K derived: sum of 3 quarters · filed 2018-03-15 | $45.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-03-31 | -$88.00K 10-Q · filed 2017-05-09 | $154.00K derived: sum of 2 quarters · filed 2018-03-15 | $154.00K derived: sum of 3 quarters · filed 2018-03-15 | $593.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2015-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $242.00K derived: sum of 2 quarters · filed 2018-03-15 | $681.00K derived: sum of 3 quarters · filed 2018-03-15 | $681.00K 10-K · filed 2018-03-15 | ||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $439.00K derived: sum of 2 quarters · filed 2016-11-03 | $439.00K 10-Q · filed 2016-11-03 | $439.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-06-30 | $439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $439.00K 10-Q · filed 2016-08-04 | $439.00K derived: sum of 3 quarters · filed 2017-03-02 | $439.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | |||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $109.00K 10-K · filed 2017-03-02 | |||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $109.00K 10-Q · filed 2015-11-05 | ||||||||||
| 2014-06-30 | $109.00K 10-Q · filed 2015-08-10 | |||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 36 month − 10-K 33 month · filed 2014-05-08 | -$5.00K derived: sum of 2 quarters · filed 2014-05-08 | -$5.00K derived: sum of 3 quarters · filed 2014-05-08 | -$5.00K derived: sum of 4 quarters · filed 2014-05-08 | $88.00K 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | -$5.00K derived: 10-K 33 month − 10-Q 30 month · filed 2014-02-27 | -$5.00K derived: sum of 2 quarters · filed 2014-02-27 | -$5.00K derived: sum of 3 quarters · filed 2014-02-27 | -$5.00K 10-K · filed 2016-02-26 | $88.00K 10-K · filed 2014-02-27 | |||||||
| 2013-09-30 | $0.00 derived: 10-Q 30 month − 10-Q 27 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 derived: sum of 3 quarters · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2015-03-16 | $93.00K 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | $0.00 derived: 10-Q 27 month − 10-Q 24 month · filed 2013-08-13 | $0.00 derived: sum of 2 quarters · filed 2013-08-13 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 derived: sum of 4 quarters · filed 2015-03-16 | $93.00K 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | $0.00 derived: 10-Q 24 month − 10-K 21 month · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $93.00K 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $93.00K 10-K · filed 2015-03-16 | $93.00K 10-K · filed 2013-02-25 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $93.00K 10-Q · filed 2013-11-13 | $93.00K 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $93.00K 10-Q · filed 2013-08-13 | $93.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |